Latest News
FDA Approves Incyte's Zynyz® (retifanlimab-dlwr) for the Treatment of Adults With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal (SCAC)
Details >FDA Approves AbbVie's EMRELIS™ (telisotuzumab vedotin-tllv) for Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression
Details >Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
